Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Dose-Response Relationship, Drug »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopaminergic Neurons (transplantation) < Dose-Response Relationship, Drug < Dose-Response Relationship, Immunologic  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 332.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000050 (1999) R. Ceravolo [Royaume-Uni] ; S. Salvetti ; P. Piccini ; C. Lucetti ; G. Gambaccini ; U. BonuccelliAcute and chronic effects of clozapine in essential tremor.
000052 (1999) M. Merello [Argentine] ; A J Lees ; J. Balej ; A. Cammarota ; R. LeiguardaGPi firing rate modification during beginning-of-dose motor deterioration following acute administration of apomorphine.
000053 (1999) H H Fernandez [États-Unis] ; J H Friedman ; C. Jacques ; M. RosenfeldQuetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
000062 (1999) S. Spieker [Allemagne] ; P A Löschmann ; T. KlockgetherThe NMDA antagonist budipine can alleviate levodopa-induced motor fluctuations.
000101 (1999) R K Pearce [Royaume-Uni]L-dopa and dyskinesias in normal monkeys.
000102 (1999) M. Vidailhet [France] ; A M Bonnet ; R. Marconi ; F. Durif ; Yves Agid [France]The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease.
000103 (1999) O. Rascol [France]L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
000107 (1999) P. Damier [France] ; C. Jaillon ; I. Clavier ; I. Arnulf ; A M Bonnet ; B P Bejjani ; Yves Agid [France]Dyskinesias assessment in Phase II studies.
000108 (1999) H. Widner [Suède] ; G L DeferDyskinesias assessment: from CAPIT to CAPSIT. Core Assessment Program for Intracerebral Transplantations. Core Assessment Program for Surgical Interventional Therapies.
000114 (1999) J L Montastruc [France] ; O. Rascol ; J M SenardTreatment of Parkinson's disease should begin with a dopamine agonist.
000117 (1999) B. Henry [Royaume-Uni] ; S H Fox ; D. Peggs ; A R Crossman ; J M BrotchieThe alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease.
000138 (1999) E S Molho [États-Unis] ; S A FactorPossible tardive dystonia resulting from clozapine therapy.
000141 (1999) E A Sekul [États-Unis] ; S. Kaminer ; K D SethiDigoxin-induced chorea in a child.
000149 (1999) Yves Agid [France] ; E. Ahlskog ; A. Albanese ; D. Calne ; T. Chase ; J. De Yebenes ; S. Factor ; S. Fahn ; O. Gershanik ; C. Goetz ; W. Koller ; M. Kurth ; A. Lang ; A. Lees ; P. Lewitt ; D. Marsden ; E. Melamed ; P P Michel ; Y. Mizuno ; J. Obeso ; W. Oertel ; W. Olanow ; Werner Poewe [Autriche] ; P. Pollak ; E. TolosaLevodopa in the treatment of Parkinson's disease: a consensus meeting.
000153 (1999) J E Ahlskog [États-Unis] ; R J Uitti ; M K O'Connor ; D M Maraganore ; J Y Matsumoto ; K F Stark ; M F Turk ; O L BurnettThe effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease.
000166 (1999) T. Mezaki [Japon] ; R. Kaji ; M F Brin ; M. Hirota-Katayama ; T. Kubori ; T. Shimizu ; J. KimuraCombined use of type A and F botulinum toxins for blepharospasm: a double-blind controlled trial.
000200 (2000) L M Shulman [États-Unis] ; A. Minagar ; W J WeinerThe effect of pregnancy in Parkinson's disease.
000208 (2000) H. Apaydin [Turquie] ; S. Ertan ; S. OzekmekçiBroad bean (Vicia faba)--a natural source of L-dopa--prolongs "on" periods in patients with Parkinson's disease who have "on-off" fluctuations.
000230 (2000) T A Zesiewicz [États-Unis] ; M. Helal ; R A HauserSildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease.
000235 (2000) V G Evidente [États-Unis] ; C H Adler ; J N Caviness ; J G Hentz ; K. Gwinn-HardyAmantadine is beneficial in restless legs syndrome.
000260 (2000) C G Goetz [États-Unis] ; T Q Vu ; P M Carvey ; S. LeurgansPosthypoxic myoclonus in the rat: natural history, stability, and serotonergic influences.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Dose-Response Relationship, Drug" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Dose-Response Relationship, Drug" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dose-Response Relationship, Drug
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024